Top Stories
The deal gives Medtronic rights to distribute Cornerstone's Sentire surgical system in select markets outside the US.
The 14-day wearable cut the median time to diagnosis from 55 days to 22 days and was linked to more treatment for rhythm disorders.
The AI identified higher cardiovascular risk even in patients whose scans showed no coronary calcium.
Vivid Explorer, Vivid Advanced and Vivid Focus have all received CE marking in the EU and are pending FDA 510(k) clearance in the US.
Results from the independent study could support routine use of the FDA-cleared platform in clinical practice.
Conference News
1-Sep-2026 at 11:15 AM EDT, by American Society of Anesthesiologists (ASA)CHICAGO – The American Society of Anesthesiologists (ASA) today announced the continuation of its longstanding collaboration w...
Studies examine long-term PAP outcomes, personalized approaches to care and new technologies that could help identify obstructive sleep apnea (OSA) earlierLondon, September 1, 2026 – Resmed (NYSE: RMD...
Three Hot Line trials from ESC Congress 2026 – ASPIRED, DANISH-CRT, and His-Alternative II – test 14-day ECG monitoring in patients with unexplained syncope, compare cardiac resynchronization therapy ...
Data highlight translational NGS approaches to refine patient stratification, guide target selection, and accelerate precision drug development in hematologic malignanciesWALTHAM, Mass.--(BUSINESS WIR...
SAN DIEGO, CA, UNITED STATES, August 31, 2026 /EINPresswire.com/ -- At ACS Clinical Congress 2026, ZMED will demonstrate how surgical video can extend beyond recording to support structured surgical d...
